Sitemap - 2017 - Mendelspod
A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein
Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
Huh? 30 Million Americans Have a Rare Disease? Howard Jacob on the State of Clinical Sequencing
With their Own Manufacturing Facility, Seattle Children’s Goes Big into CAR-T, Rare Disease
With Immuno Oncology Comes a New Focus on Rare Cells
We've Become Too Single Variant Centric, Says Deanna Church on Genome Analysis
Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai
September 2017 with Nathan and Laura: Venter Blunder, RNAi Returns, and Monthly Science Moments
Charting the Dark Matter of Cancer Genomes with Jim Broach
Why Childhood Cancers Need Their Own Gene Panel: Tim Triche
Exploring the Exome and the Future of Genomics with Jay Shendure
The First In-Human Gene Editing Trial in the U.S. - And It’s Not with CRISPR
Thermo, Pfizer, and Novartis Pull Off a First for NGS in Lung Cancer
Making Genetic Testing Mainstream Medicine with Sean George, Invitae
Need Better Standards for Your Clinical Assays? NIST Can Help
Turning on Your DNA with Justin Kao, Helix
George Church on What Comes After CRISPR
Is CRISPR Controversy Science or Spin? June 2017 Review with Nathan and Laura
We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD
Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape
The Last Major Disease To Be Studied? Ron Davis of Stanford Thinks So
On Bioinformatics Data Sharing and Collaboration: Andrew Carroll, DNAnexus
Is Population Medicine Failing Us? Michel Accad
Deep Omics Profiler, Mike Snyder, Now Turns to Wearables
Over $1 Billion Invested this Past Year: Synthetic Biology in 2017 with John Cumbers
Green Light for DTC, Blood Mammograms, and Ancient DNA: April 2017 with Nathan and Laura
With 50 Million Users, Is Academia.edu Speeding Up Science?
How to Improve Lab Tests in the Absence of FDA Regulation?
Known for Medical Devices, 116 Yr Old BD Makes a Bold Move in Genomics
Proposed NIH Cuts, Undermining GINA, and Game Changing Drugs: March 2017 with Nathan and Laura
Art in the Lab (Falling in Love with Bacteria)
Flint Whistleblower Says Today's Science Is to Blame for Its Own Lack of Public Trust
The Story of Geisinger and Doing Genomic Medicine at the Right Pace
In-Situ Sequencing, CRISPR Patents, and Racist Milk Drinkers: February 2017 with Nathan and Laura
New Pocket Size Nanopore Device Could Revolutionize Diagnostic and Other Testing
By Changing a Basic Lab Step, Acoustic Liquid Transfer Having a Broad Impact
Many Biologists Today Don’t Have Enough Computer Science to Use the Databases
Cardiologists Love Genomics: Euan Ashley, Stanford
Scientists vs Trump: January 2017 with Nathan and Laura
Want to Stop Smoking? Start with Epigenetic Biomarker that Tells Doc the Truth
People Told Us It Was Impossible: UCSC’s Mark Akeson on Nanopore Sequencing
When Long Reads are Double the Price of Short Reads, Short Reads Are Dead, Says Evan Eichler